Summary
A trans-Tasman bubble should look beyond short-term tourism and use the opportunity to push manufacturing and trade integration between Australia and New Zealand to reduce reliance on Chinese supply chains, writes Hongzhi Gao, an associate professor at Victoria University of Wellington. The article cites New Zealand retailer The Warehouse: in 2017 about 60 percent of its private-label goods were sourced from China, and in 2019 it directly procured NZ$62 million worth of goods through offices in China, India and Bangladesh. Data show China accounted for 20 percent of global trade in intermediate goods in 2018, and 35 percent of household goods, 46 percent of high-tech products, 54 percent of textiles and clothing, 38 percent of machinery rubber and plastics, 20 percent of pharmaceuticals and medical supplies, and 42 percent of chemical products.
In 2019, New Zealand's exports to China accounted for 23 percent of its total exports, worth NZ$20 billion, and about one-fifth of exported products contained China-made components. After the COVID-19 outbreak in early 2020, supplies of everything from cars and iPhones to food ingredients and hand sanitiser packaging fluctuated, and common over-the-counter painkillers such as paracetamol were in limited supply at one point as Chinese factories halted production; more than 90 percent of Australia's medicines rely on imports, and New Zealand imported nearly NZ$1.59 billion of pharmaceuticals in 2019. The article recommends the two countries develop a collaborative trans-Tasman manufacturing strategy, pool R&D resources, invest directly in each other, and use profits from markets such as China to subsidise R&D and manufacturing in emerging markets; medical technology and telecommunications equipment manufacturing are seen as potential new areas for integration, with Res-Med Australia and New Zealand's Fisher & Paykel Healthcare rapidly expanding capacity for respiratory equipment, ventilators and personal protective equipment during the pandemic, and New Zealand's Tait Communication also mentioned.
Commentary
Discussion of a trans-Tasman bubble has focused mostly on tourism recovery, but Associate Professor Gao's manufacturing integration perspective is more strategically significant for Australian and New Zealand SMEs. China accounts for 20 percent of global trade in intermediate goods and 35 to 54 percent in areas such as household goods, high-tech and textiles and clothing, and about one-fifth of New Zealand's exports contain Chinese components; the risk of supply chain concentration was laid bare during the pandemic, as evidenced by paracetamol shortages and competition for medical supplies. For import-dependent New Zealand SMEs, Australia-NZ manufacturing coordination can reduce single-source risk, but it must be recognised that China remains the largest trading partner for both countries, with 23 percent of New Zealand's exports going to China, and full decoupling is unrealistic.
A more pragmatic path is a 'China plus one' strategy: while retaining access to the Chinese market, leverage the geographical proximity and institutional similarities of Australia and New Zealand to cultivate regional supply chains in high-value areas such as medical technology and telecommunications equipment. The rapid expansion of Fisher & Paykel Healthcare and Res-Med has already shown the complementary potential of Australia and New Zealand in medical device manufacturing, and Tait Communication's private network communications technology could also play a role in regional emergency communications networks. SMEs should watch whether the Australian and New Zealand governments introduce policies such as joint procurement, R&D tax credits or simplified rules of origin, which will directly affect the cost and feasibility of restructuring cross-border supply chains.
Keywords: trans-Tasman bubble, supply chain dependence, Made in China, Australia-NZ trade integration, manufacturing strategy, medical supplies, R&D cooperation, exports to China
Photo by EclipseChasers on Pixabay
Source: The Times Australia
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.






